Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1898-1905

  Beekman, Nico J ^a   Van Veelen, Peter A ^a   Van Hall, Thorbald ^a   Neisig, Anne ^b   Sijts, Alice ^c   Camps, Marcel ^a   Kloetzel, Peter M ^c   Neefjes, Jacques J ^b   Melief, Cornelis J ^a   Ossendorp, Ferry ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; SYNTHETIC PEPTIDE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EMBRYO; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TUMOR CELL;

EID: 18344412660     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1898     Document Type: Article

References (51)

1. Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and the 26S proteasomes. Annu. Rev. Biochem. 65:801.
2. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:739.
3. Heemels, M. T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463.
4. Androlewicz, M. J., and P. Creswell. 1996. How selective is the transporter associated with antigen processing? Immunity 5:1.
5. Rock, K. L., G. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldherg. 1994. Inhibitors of the proteasome block degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules. Cell 78:761.
6. Cerundolo, V., A. Benham, V. Braud, S. Mukherjee, K. Gould, B. Macino, J. Neefjes, and A. Townsend. 1997. The proteasome-specific inhibitor lactacystin blocks the presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27:336.
7. Benham, A. M., and J. J. Neefjes. 1997. Proteasome activity limits the assembly of MHC class I molecules after IFN-γ stimulation. J. Immunol. 159:5896.
8. Gaczynska, M., K. L. Rock, and A. L. Goldberg. 1993. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264.
9. Boes, B., H. Hengel, T. Ruppert, G. Multhaup, U. H. Koszinowski, and P. M. Kloetzel. 1994. Interferon y stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasome. J. Exp. Med. 179:901.
10. Griffin, T. A., D. Nandi, M. Cruz, H. J. Fehling, L. V. Kaer, J. J. Monaco, and R. A. Colbert. 1998. Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN γ)-inducible subunits. J. Exp. Med 187:97.
11. Dick, L. R., C. Aldrich, S. C. Jameson, C. R. Moonaw, B. C. Pramanik, C. K. Doyle, G. N. DeMartino, M. J. Bevan, J. M. Forman, and C. A. Slaughter. 1994. Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152:3884.
12. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschütsky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
13. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengedé, P.-M. Kloetzel, J. J. Neefjes, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115.
14. Nussbaum, A. K., T. P. Dick, W. Keilholz, M. Schirle, S. Stevanovic, K. Dietz, W. Heinemeyer, M. Groll, D. H. Wolf, R. Huber, et al. 1998. Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase 1. Proc. Natl. Acad. Sci. USA 95:12504.
15. Eggers, M., B. Boes-Fabian, T. Ruppert, P.-M. Kloetzel, and U. H. Koszinowski. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182:1865.
16. Dick, T. P., S. Stevanovic, W. Keilholz, T. Ruppert, U. Koszinowski, H. Schild, and H. G. Rammensee. 1998. The making of the dominant MHC class I ligand SYFPEITHI. Eur. J. Immunol. 28:2478.
17. Craiu, A., T. Akopian, A. Goldberg, and K. Rock. 1997. Two distinct proteolytic processes in the generation of a major histocompatibility complex class-I presented peptide. Proc. Natl. Acad. Sci. USA 94:10850.
18. Stoltze, L., T. P. Dick, M. Deeg, B. Pommerl, H. G. Rammensee, and H. Schild. 1998. Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities. Eur. J. Immunol. 28:4029.
19. Roelse, J., M. Grommé, F. Momburg, G. Hammerling, and J. Neefjes. 1994. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1591.
20. Elliott, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompatibility class-I restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
21. Snyder, H. L., J. W. Yewdell, and J. R. Bennink. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389.
22. Beninga, J., K. L. Rock, and A. L. Goldberg. 1998. Interferon-γ can stimulate post-proieasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273:18734.
23. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:1335.
24. Del Val, M., H. J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145.
25. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influences the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481.
26. Shastri, N., T. Serwold, and F. Gonzalez. 1995. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues. J. Immunol. 155:4229.
27. Yellen-Shaw, A. J., and L. C. Eisenlohr. 1997. Regulation of class I restricted epitope processing by local or distant flanking sequence. J. Immunol. 158:1727.
28. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248.
29. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steiger Wald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by internal repeat region of the EBV EBNA-1 antigen. Nature 375:685.
30. Rotem-Yehudar, R., M. Groettrup, A. Soza, P. M. Kloetzel, and R. Ehrlich. 1996. LMP-associated proteolytic activities and TAP-dependent peptide transport for class I MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J. Exp. Med. 183:499.
31. b mutant bm13 mice. J. Virol. 68:6038.
32. Milan, G., A. Zambon, M. Cavinato, P. Zanovello, A. Rosato, and D. Collavo. 1999. Dissecting the immune response to Moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach. J. Virol. 73: 2280.
33. Gausepohl, H., M. Kraft, C. Boulin, and R. W. Frank. 1990. Automated multiple peptide synthesis with BOP activation. In Proceedings of the Eleventh American Peptide Symposium, J. E. Rivier and G. R. Marshall, eds. ESCOM, Leiden, p. 1003.
34. Groettrup, M., T. Ruppert, L. Kuehn, M. Seeger, S. Standera, U. Koszinowski, and P. M. Kloetzel. 1995. The interferon-γ inducible 11S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20S proteasome in vitro. J. Biol. Chem. 270:23808.
35. Traversari, C., P. van der Bruggen, B. van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L. Old, and T. Boon. 1992. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous CTL. Immunogenetics 35:145.
36. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726.
37. Bogyo, M., J. S. McMaster, M. Gaczynska, D. Tortorella, A. Goldberg, and H. Ploegh. 1997. Covalent modification of the active site threonine of proteasomal β subunits and the E. coli homologue HsIV by a new class of inhibitors. Proc. Natl. Acad. Sci USA 94:6629.
38. Stukart, M. J., A. Vos, and C. J. M. Melief. 1981. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus: methodological aspects and H-2 requirements. Eur. J. Immunol. 11:251.
39. Storkus, W. J., H. J. Zeh III, R. D. Salter, and M. T. Lotze. 1993. Identification of T cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14:94.
40. Toes, R. E. M., R. Offringa, R. J. J. Blom, R. M. P. Brandt, A. J. van der Eb, C. J. M. Melief, and W. M. Kast. 1995. An adenovirus 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J. Immunol. 154:3396.
41. Schoenberger, S. P., L. E. Jonges, R. D. Mooijaart, F. Hartgers, R. E. M. Toes, W. M. Kast, C. J. M. Melief, and R. Offringa. 1998. Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC. Cancer Res. 58:3094.
42. Neisig, A., J. Roelse, A. J. A. M. Sijts, F. Ossendorp, M. C. W. Feltkamp, W. M. Kast, C. J. M. Melief, and J. J. Neefjes. 1995. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides. J. Immunol. 154:1273.
43. Feltkamp, M. C. W., H. L. Smits, M. P. M. Vierboom, R. P. Minnaar, B. M. De Jongh, J. W. Drijfhout, J. Ter Scheggel, C. J. M. Melief, and W. M. Kast. 1993. Vaccination with a cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23:2242.
44. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
45. Momburg, F., J. Roelse, J. C. Howard, G. W. Butcher, G. J. Hämmerling, and J. J. Neefjes. 1994. Selectivity of MHC encoded peptide transporters from human, mouse and rat. Nature 367:648.
46. Feltkamp, M. C. W., M. P. M. Vierboom, W. M. Kast, and C. J. M. Melief. 1994. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol. Immunol. 31:1391.
47. Kast, W. M., L. Roux, J. Curren, H. J. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofski, and C. J. M. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with an unbound peptide. Proc. Natl. Acad. Sci. USA 88:2283.
48. Ossevoort, M. A., A. J. A. M. Sijts, K. J. H. van Veen, F. Momburg, G. J. Hämmerling, A. Seelig, G. W. Butcher, J. C. Howard, W. M. Kast, and C. J. M. Melief. 1993. Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing. Eur. J. Immunol. 23:3082.
49. Paz, P., N. Brouwenstijn, R. Perry, and N. Shastri. 1999. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. Immunity 11:241.
50. Theobald, M., T. Ruppert, U. Kuckelkorn, J. Hernandez, A. Häussler, E. A. Ferreira, U. Liewer, J. Biggs, A. J. Levine, C. Huber, U. H. Koszinowski, P. M. Kloetzel, and L. A. Sherman. 1998. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J. Exp. Med. 188:1017.
51. Chen, W., H. Qin, B. Chesebro, and M. A. Cheever. 1996. Identification of a gag-encoded cytotoxic T lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney and Rauscher murine leukemia virus-induced tumors. J. Virol. 70:7773.